Sinocare Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.072x

Sinocare Inc cash flow conversion efficiency. Based on the latest financial reports, Sinocare Inc (300298) has a cash flow conversion efficiency ratio of 0.072x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥264.19 Million ≈ $38.66 Million USD) by net assets (CN¥3.67 Billion ≈ $537.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sinocare Inc (2008–2024)

Cash flow conversion efficiency of Sinocare Inc from 2008 to 2024. This chart illustrates how Sinocare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sinocare Inc share price for real-time trading data and today's change.

Sinocare Inc Cash Flow Conversion Ratio Explained

Sinocare Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sinocare Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinocare Inc ranked by their cash flow conversion efficiency. Also see 300298 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
China National Accord Medicines Corp Ltd SHE:000028	-0.020x
Airport City Ltd TA:ARPT	0.013x
Formula TA:FORTY	0.230x
Beijing Xinleineng Technology Co Ltd SHE:300593	-0.024x
Shaanxi Aerospace Power Hi-Tech Co Ltd SHG:600343	-0.015x
YOUZU Interactive Co Ltd SHE:002174	0.007x
Kosmos Energy Ltd NYSE:KOS	0.207x
Shinsegae KO:004170	0.029x

Annual Cash Flow Conversion Efficiency for Sinocare Inc (2008–2024)

The table below shows the annual cash flow conversion efficiency of Sinocare Inc from 2008 to 2024. Review 300298 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.77 Billion ≈ $551.61 Million	CN¥631.29 Million ≈ $92.38 Million	0.167x	-20.94%
2023-12-31	CN¥3.47 Billion ≈ $507.88 Million	CN¥735.15 Million ≈ $107.57 Million	0.212x	+40.36%
2022-12-31	CN¥3.14 Billion ≈ $460.00 Million	CN¥474.39 Million ≈ $69.42 Million	0.151x	-12.21%
2021-12-31	CN¥2.79 Billion ≈ $408.61 Million	CN¥480.03 Million ≈ $70.24 Million	0.172x	-6.63%
2020-12-31	CN¥2.74 Billion ≈ $401.11 Million	CN¥504.64 Million ≈ $73.84 Million	0.184x	-6.72%
2019-12-31	CN¥2.65 Billion ≈ $387.62 Million	CN¥522.81 Million ≈ $76.50 Million	0.197x	+62.15%
2018-12-31	CN¥2.62 Billion ≈ $383.83 Million	CN¥319.27 Million ≈ $46.72 Million	0.122x	-30.65%
2017-12-31	CN¥1.39 Billion ≈ $203.34 Million	CN¥243.89 Million ≈ $35.69 Million	0.176x	+10.25%
2016-12-31	CN¥1.28 Billion ≈ $186.99 Million	CN¥203.42 Million ≈ $29.77 Million	0.159x	+62.46%
2015-12-31	CN¥1.24 Billion ≈ $181.47 Million	CN¥121.52 Million ≈ $17.78 Million	0.098x	-28.90%
2014-12-31	CN¥1.11 Billion ≈ $162.61 Million	CN¥153.15 Million ≈ $22.41 Million	0.138x	+13.95%
2013-12-31	CN¥946.01 Million ≈ $138.43 Million	CN¥114.42 Million ≈ $16.74 Million	0.121x	-20.83%
2012-12-31	CN¥845.18 Million ≈ $123.68 Million	CN¥129.12 Million ≈ $18.89 Million	0.153x	-68.09%
2011-12-31	CN¥179.51 Million ≈ $26.27 Million	CN¥85.93 Million ≈ $12.57 Million	0.479x	-34.81%
2010-12-31	CN¥91.35 Million ≈ $13.37 Million	CN¥67.08 Million ≈ $9.82 Million	0.734x	-29.18%
2009-12-31	CN¥41.49 Million ≈ $6.07 Million	CN¥43.03 Million ≈ $6.30 Million	1.037x	+136.80%
2008-12-31	CN¥17.42 Million ≈ $2.55 Million	CN¥7.63 Million ≈ $1.12 Million	0.438x	--

About Sinocare Inc

SHE:300298 China Medical Devices

Market Cap

$1.54 Billion

CN¥10.51 Billion CNY

Market Cap Rank

#6856 Global

#1352 in China

Share Price

CN¥18.75

Change (1 day)

+0.00%

52-Week Range

CN¥13.65 - CN¥19.68

All Time High

CN¥47.34